Jose A Gómez-Puerta

Associate Professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jose A Gómez-Puerta is an Associate Professor at the Universitat de Barcelona, Spain. His research interests include the clinical and ultrasound characteristics of psoriatic arthritis, the classification criteria for antiphospholipid syndrome, and the management of systemic lupus erythematosus. He has contributed to various studies that focus on ultrasound diagnostics and the rheumatologic complications associated with CAR-T cell therapy.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Carolina Muñoz Grajales

Assistant professor

University of Manitoba

CANADA

View details

Andreas Kronbichler

Medical University of Innsbruck

AUSTRIA

View details

Laura ANDREOLI

University of Brescia

ITALY

View details

Luís Sousa Inês

Assistant Professor

University of Coimbra

PORTUGAL

View details

Stéphane Zuily

Université de Lorraine

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jose A Gómez-Puerta

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Clinical and Ultrasound Characteristics of a Difficult-to-Treat Psoriatic Arthritis Population

Obituary for José Muñoz Gómez, MD, FRCP (1939–2024)

Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions.

Ultrasound: a useful tool for diagnosing tibial stress fractures

Ultrasound-detected lumps in synovial fluid, a sonographic finding associated with non-inflammatory joint effusion.

Dual B-cell targeting in systemic lupus erythematosus: The role of combined and sequential therapy with rituximab and belimumab.

ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations.

Rheumatologic complications of CAR-T Cell therapy. Experience of a single center

Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force.

Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set.

2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria

Controversies in the Management of Antiphospholipid Syndrome.

From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies.

Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors

Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus.

Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report

Another step in lupus nephritis

Un paso más en la nefritis lúpica

Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors.

Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis

Collaborators (5)

Carolina Muñoz Grajales

Andreas Kronbichler

Laura ANDREOLI

Luís Sousa Inês

Stéphane Zuily

Make your next move.

Jose A Gómez-Puerta

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Clinical and Ultrasound Characteristics of a Difficult-to-Treat Psoriatic Arthritis Population

Obituary for José Muñoz Gómez, MD, FRCP (1939–2024)

Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions.

Ultrasound: a useful tool for diagnosing tibial stress fractures

Ultrasound-detected lumps in synovial fluid, a sonographic finding associated with non-inflammatory joint effusion.

Dual B-cell targeting in systemic lupus erythematosus: The role of combined and sequential therapy with rituximab and belimumab.

ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations.

Rheumatologic complications of CAR-T Cell therapy. Experience of a single center

Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force.

Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set.

2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria

Controversies in the Management of Antiphospholipid Syndrome.

From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies.

Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors

Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus.

Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report

Another step in lupus nephritis

Un paso más en la nefritis lúpica

Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors.

Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis

Collaborators (5)

Carolina Muñoz Grajales

Andreas Kronbichler

Laura ANDREOLI

Luís Sousa Inês

Stéphane Zuily

Make your next move.

Ultrasound-detected lumps in synovial fluid, a sonographic finding associated with non-inflammatory joint effusion.